Privia Health Group, Inc. (PRVA) stock
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3081% above fair value
$24.99−0.27 (-1.07%)
Close on Nov 17, 2026Market cap $3.19BP/E 119.0Yield –
Privia Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Privia Health's revenue for the twelve months ending Jun 30, 2026 was $2.36B, up 24.1% year over year. For fiscal 2025 it was $2.12B, up 22.3% from the year before. The highest annual figure on record is $2.12B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.12B | +22.3% |
| FY2024 | Dec 31, 2024 | $1.74B | +4.7% |
| FY2023 | Dec 31, 2023 | $1.66B | +22.2% |
| FY2022 | Dec 31, 2022 | $1.36B | +40.4% |
| FY2021 | Dec 31, 2021 | $966.22M | +18.3% |
| FY2020 | Dec 31, 2020 | $817.08M | +3.9% |
| FY2019 | Dec 31, 2019 | $786.36M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $632.63M | +21.4% |
| Q1 FY2026 | Mar 31, 2026 | $603.85M | +25.8% |
| Q4 FY2025 | Dec 31, 2025 | $541.17M | +17.4% |
| Q3 FY2025 | Sep 30, 2025 | $580.42M | +32.5% |
| Q2 FY2025 | Jun 30, 2025 | $521.15M | +23.4% |
| Q1 FY2025 | Mar 31, 2025 | $480.10M | +15.6% |
| Q4 FY2024 | Dec 31, 2024 | $460.90M | +4.6% |
| Q3 FY2024 | Sep 30, 2024 | $437.92M | +4.9% |
| Q2 FY2024 | Jun 30, 2024 | $422.33M | +2.2% |
| Q1 FY2024 | Mar 31, 2024 | $415.24M | +7.5% |
| Q4 FY2023 | Dec 31, 2023 | $440.83M | +21.0% |
| Q3 FY2023 | Sep 30, 2023 | $417.28M | +21.7% |
| Q2 FY2023 | Jun 30, 2023 | $413.35M | +23.2% |
| Q1 FY2023 | Mar 31, 2023 | $386.28M | +23.1% |
| Q4 FY2022 | Dec 31, 2022 | $364.42M | +32.4% |
| Q3 FY2022 | Sep 30, 2022 | $342.90M | +36.3% |
| Q2 FY2022 | Jun 30, 2022 | $335.54M | +48.6% |
| Q1 FY2022 | Mar 31, 2022 | $313.80M | +46.9% |
| Q4 FY2021 | Dec 31, 2021 | $275.33M | +28.8% |
| Q3 FY2021 | Sep 30, 2021 | $251.52M | +21.4% |
| Q2 FY2021 | Jun 30, 2021 | $225.76M | +23.2% |
| Q1 FY2021 | Mar 31, 2021 | $213.61M | +0.3% |
| Q4 FY2020 | Dec 31, 2020 | $213.70M | – |
| Q3 FY2020 | Sep 30, 2020 | $207.17M | – |
| Q2 FY2020 | Jun 30, 2020 | $183.26M | – |
| Q1 FY2020 | Mar 31, 2020 | $212.94M | – |
See a number that looks wrong?